ClinicalTrials.govpublic full text
Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)
chronic coronary syndrome, stable coronary artery disease cad, dapt, cabg, prasugrel, aspirin, ccs, stable coronary artery disease, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 901424
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.